The Technical Analyst
Select Language :
Anchiano Therapeutics Ltd [CMMB]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Anchiano Therapeutics Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals

Anchiano Therapeutics Ltd is listed at the  Exchange

2.80% $0.770

America/New_York / 27 mar 2024 @ 16:00


Anchiano Therapeutics Ltd: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 10.49 mill
EPS: -2.94
P/E: -0.260
Earnings Date: May 09, 2024
SharesOutstanding: 13.62 mill
Avg Daily Volume: 0.244 mill
RATING 2024-03-27
B-
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.260 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.04x
Company: PE -0.260 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.764
(-0.79%) $-0.0061
Date: 2024-03-28
Expected Trading Range (DAY)

$ 0.710 - 0.830

( +/- 7.79%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-06-14 Darvish Nissim Buy 20 572 Option to Purchase American Depositary Shares
2021-04-19 Darvish Nissim Buy 11 884 Option to Purchase American Depositary Shares
2016-10-28 Darvish Nissim Buy 10 123 Option to Purchase American Depositary Shares
2023-03-16 Darvish Nissim Buy 6 857 Option to Purchase American Depositary Shares
2022-03-07 Darvish Nissim Buy 6 820 Option to Purchase American Depositary Shares
INSIDER POWER
-56.89
Last 88 transactions
Buy: 2 375 207 | Sell: 4 584 307

Forecast: 16:00 - $0.751

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.751
Forecast 2: 16:00 - $0.751
Forecast 3: 16:00 - $0.751
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.770 (2.80% )
Volume 0.0480 mill
Avg. Vol. 0.244 mill
% of Avg. Vol 19.71 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Anchiano Therapeutics Ltd

Last 12 Months

Last 12 months chart data with high, low, open and close for Anchiano Therapeutics Ltd

RSI

Intraday RSI14 chart for Anchiano Therapeutics Ltd

Last 10 Buy & Sell Signals For CMMB

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Anchiano Therapeutics Ltd

CMMB

Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.

Last 10 Buy Signals

Date Signal @
IMXUSDMar 28 - 05:23$2.98
FTMUSDMar 28 - 05:22$1.023
ETCUSDMar 28 - 05:22$32.22
SANDUSDMar 28 - 05:21$0.695
EOSUSDMar 28 - 05:21$1.064
PEOPLEUSDMar 28 - 05:190.0396
FXSUSDMar 28 - 05:19$7.71
CBKUSDMar 28 - 05:191.082
ICXUSDMar 28 - 05:19$0.355
^NSEBANKMar 28 - 05:20PTS47 332

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.